Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
3
institutions
Market cap
$2.3B
374M shares
52-week range
$4.33 – $8.69
46% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
CS
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
www.bauschhealth.comNo one on the platform currently holds BHC.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,575,772 | $8.5M |
| Bridgewater Associatesas of 2026-03-31 | 670,366 | $3.6M |
No one on the platform has traded BHC yet.
| 350,000 |
| $2.4M |
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $10.7B | +4.0% | $4.38 | $4.25–$4.52 | 1.4× | 3 |
| 2027 | $10.7B | +0.0% | $4.11 | $3.91–$4.36 | 1.5× | 3 |
| 2028 | $9.8B | -8.4% | $3.01 | $2.98–$3.07 | 2.1× | 1 |
| 2029 | $9.4B | -3.3% | $2.80 | $2.76–$2.85 | 2.3× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-29 | $0.96 | $1.26 | +31.3% |
| 2026-04-29 | $0.81 | $0.78 | -3.7% |
| 2026-02-18 | $1.21 | $1.08 | -10.7% |
| 2025-10-29 | $1.07 | $1.16 | +8.4% |
| 2025-07-30 | $0.97 | $0.90 | -7.2% |
| 2025-04-30 | $0.83 | $0.59 | -28.9% |
| 2025-02-19 | $1.65 | $1.15 | -30.3% |
| 2024-10-30 | $1.03 |
| $1.12 |
| +8.7% |
| $4.5B |
| — |
| CPRXCatalyst Pharmaceuticals, Inc. | $31.49 | +0.00% | $3.9B | — |
| HAEHaemonetics Corporation | $90.38 | -1.05% | $4.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$BHC ...2BULLS... ... ...We good Warriors... ...Holding well... ...
View on StockTwits ↗$BHC To the new Board Members at $BLCO. One week on the job and your options/grants are already 5% under water. Welcome to our world!
View on StockTwits ↗$BHC bullish options flow. Seeing $8CALLS for September. Maybe best to just have shares…
View on StockTwits ↗$BHC don't wanna jinx it but I believe something going to finally happen with blco soon especially with the new board members
View on StockTwits ↗$BHC sorry guys, my bad, got my hopes up so of course BHC has to tank right after my post.
View on StockTwits ↗$BHC higher high and higher low would be nice, see if we can finally start building up here. I've also only been here a few months so BHC hasn't destroyed my optimism fully yet.
View on StockTwits ↗Wall St is expecting 1.26 EPS for $BHC Q3 [Reporting 10/29 AMC] http://www.estimize.com/intro/bhc?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗$BHC saw a post from a while back where his strategy with BHC was to buy in the low $5’s and sell in the high $6’s. Wash, rinse, and repeat. That guy must be crushing it
View on StockTwits ↗$BHC Bausch Health has surged nearly 28% over the past month, thanks to a strong second-quarter performance that has investors feeling optimistic about its recovery. The company's latest results show a significant turnaround, boosting its growth outlook. In the last month, Bausch Health Companies Inc. has seen a remarkable gain of 28%, driven by a solid financial report for Q2 2026. The company reported a net income of CA$260 million, a notable improvement from the previous year, and raised its full-year revenue guidance, indicating a positive trajectory. This momentum is crucial for a company that has faced challenges in recent years. https://wealthawesome.com/bausch-health-companies-inc-bhcto-soars-28-in-a-month-on-strong-q2-results
View on StockTwits ↗$BHC Share Price: $5.91 Contract Selected: Aug 28, 2026 $5 Calls Buy Zone: $0.59 – $0.73 Target Zone: $1.10 – $1.35 Potential Upside: 75% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$BHC why Thomas join blco board, 17 million a year isn’t enough he needs another 300k to do nothing. Good to see they are helping shareholders in such amazing ways. Thomas needs a raise I mean the stock price only decline 85% since he took over and has been making new lows ever now and then that should count toward a 10 million bonus for his hard work
View on StockTwits ↗$BHC when you own BHC you just have to laugh to keep from crying.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.